Arimidex 2 - Stealth Labs

Few medications have redefined hormonal therapy as decisively as anastrozole did following its release in 1995. Developed by Zeneca, it functioned by selectively inhibiting aromatase, thereby reducing estrogen levels systemically. Its precision and lack of estrogenic side activity distinguished it from drugs like tamoxifen. Widespread adoption followed the results of the ATAC trial, one of the most comprehensive head-to-head studies in hormonal oncology, which confirmed its superiority in relapse prevention.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Arimidex 2 by Stealth Labs, consult with your doctor or healthcare professional.